THE HALFAX HEIMDALL AUGUR

HIV in South Africa: Why rolling out a new shot will miss a critical ... HIV in South Africa: Why rolling out a new shot will miss a critical group of men by Paul Bowen, Rajen Govender, The Conversation edited by Sadie Harley , reviewed by Andrew Zinin Editors' notes This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked trusted source written by researcher(s) proofread The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy . The rollout, expected to begin in June 2026, prioritizes adolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs. These are the right populations to start with. But one group repeatedly slips through the cracks: adults, employed men in mobile, male-dominated indus…

HIV in South Africa: why rolling out a groundbreaking new shot will ... Adult employed men in mobile, male dominated industries, like construction, are at particular risk of HIV/Aids. They move between work sites and home, between long-term partners and casual or paid encounters. anilakkus/ iStock / Getty Images Plus The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy . The rollout, expected to begin in June 2026, prioritises adolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs. These are the right populations to start with. But one group repeatedly slips through the cracks: adult, employed men in mobile, male-dominated industries, who move between work sites and home, between long-term partners and casual or paid encounters. In epidemiology, they are a “ bridging population ”: people whose sexual networks connect higher-prevalence groups to lower-prevalence groups. In 2017, UNAIDS named the problem in its Blind Spot re…

South Africa: Different Clinics, Different Readiness. Inside the First Week of Gauteng's Lenacapavir Rollout [Health-e] This week, clinics in some of the six provinces started the rollout of Lenacapavir (LEN), an injection that has been shown to be more than 96% effective in preventing HIV with just two jabs a year. Of the 360 designated sites, 133 are in Gauteng.

HIV in South Africa: why rolling out a groundbreaking new shot will miss a critical group of men Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range.To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options. Sponsored by Sponsored by Sponsored by HIV in South Africa: why rolling out a groundbreaking new shot will miss a critical group of men Should you have feedback on this article, please complete the fields below.Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be aware that we require that you keep your feedback to below 300 words and we will consider its publication online or in Creamer Media’s print publications, at Creamer Media’s discretion.We also welcome factual corrections and tip-offs and will protect the identity of our sources, please indicate if this is your wish in your feedback below. Embed VideoPopup VideoInstagram DownloadBuy Photos 1st June 2026 ARTICLE ENQUIRYSAVE THIS ARTICLEEMAIL THIS ARTICLE Font size:-+ The first sh…

South Africa rolls out new preventive HIV shot in 'major turning point' In a potentially major advancement in the fight against HIV and AIDS, a South African laboratory is set to produce a generic version of a new preventive treatment that is injectable, and only needs to be administered twice a year. Initial studies show it reduces the risk of transmission by around 99.9%. FRANCE 24's Eunice Masson tells us more from Cape Town.

Mass rollout planned across Southern Africa for new HIV drug Administered just twice a year, the drug Lenacapavir offers near-complete protection — more than 99% — against HIV. After years of research and clinical trials, the preventive treatment has been approved and is now set to be rolled out on a large scale. Mass rollout campaigns are planned across Southern Africa — South Africa, Zambia, Eswatini, Zimbabwe, Lesotho and Mozambique — the region hardest hit by HIV/AIDS. Our team on the ground reports.

Africa: HIV in South Africa - Why Rolling Out a Groundbreaking New Shot Will Miss a Critical Group of Men [The Conversation Africa] The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, expected to begin in June 2026, prioritises adolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs.

Africa: HIV in South Africa - Why Rolling Out a Groundbreaking New Shot Will Miss a Critical Group of Men - allAfrica.com The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year,arrived in South Africafrom the United States in early April 2026. Clinical trials showedclose to 100% efficacy. The rollout, expected to begin in June 2026,prioritisesadolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs. These are the right populations to start with. But one group repeatedly slips through the cracks: adult, employed men in mobile, male-dominated industries, who move between work sites and home, between long-term partners and casual or paid encounters. In epidemiology, they are a "bridging population": people whose sexual networks connect higher-prevalence groups to lower-prevalence groups. In 2017, UNAIDS named the problem in itsBlind Spot report, showing that men across sub-Saharan Africa are less likely than women to test for HIV, less likely to be on treatment, and more likely to die of Aids-related illness. A2022 meta-analysis of 168 stud…

WC health dept says more than 1,000 people initiated on lenacapavir More than a thousand Western Cape residents have opted in for the new long-acting HIV prevention injection since, according to the Western Cape Department of Health and Wellness. The injection is designed to prevent HIV negative people from acquiring the disease. Unlike PrEP, which is taken daily as a tablet, Lenacapavir is the first injectable HIV prevention drug that provides long-acting protection against the virus for up to 28 weeks. The department said a total of 1,140 people have started using Lenacapavir, which was launched with 29,000 doses in high-risk areas in the province. At the same time, the Gauteng Department of Health recently announced that 6,000 people had taken the jab since its rollout, also on 7 June, with its target of reaching a total of 56,000 people by March next year. Lenancapavir is reported to be more than 96% effective in preventing infection and forms part of other prevention methods. Western Cape Department of Health's Shimoney Regter has expressed her thanks to Western Cape residents for taking proactive steps to secure their health. ALSO READ: New drug 'lenacapavir' 100% effective …

South Africa: Over 1,000 in Western Cape Initiated on Lenacapavir ... Western Cape Tops 1,100 Lenacapavir HIV Prevention Injections More than 1,100 people in the Western Cape have opted for the new long-acting HIV prevention injection, Lenacapavir, since its rollout in June,accordingto the provincial health department. The province has administered 1,140 injections from an initial stock of 29,000 doses in high-risk areas. Gauteng has reached 6,000 recipients. Lenacapavir, which offers up to 28 weeks of protection and is more than 96% effective at preventing HIV infection. It complements existing prevention methods such as daily oral PrEP and condoms. Suspended Ekurhuleni Legal Chief Arrested Follow us onWhatsApp|LinkedInfor the latest headlines Suspended City of Ekurhuleni Head of Legal Services Kemi Behari has been arrested, reportsEWN. Behari was implicated at the Madlanga Commission of Inquiry after evidence emerged that he allegedly shielded tainted Ekurhuleni Metropolitan Municipality Police Department (EMPD) Chief Julius Mkhwanazi from disciplinary action. He was arrested at the city's Germiston offices. In 2023, the Police Investigative Directorate (IPID) found that Mkh…

Western Cape expands HIV prevention with rollout of Lenacapavir Western Cape expands HIV prevention with rollout of Lenacapavir 08 June 2026 Tags: News HIV and AIDS Health and wellness The Western Cape Department of Health and Wellness has today commenced the phased rollout of Lenacapavir, a long-acting HIV prevention medication that offers renewed hope in the fight against HIV and expands the prevention options available to people at risk of infection. The rollout represents a significant milestone in efforts to prevent new HIV infections and forms part of a broader HIV prevention approach that includes testing, treatment services, condoms and oral pre-exposure prophylaxis (PrEP). Western Cape Minister of Health and Wellness, Mireille Wenger, said the introduction of Lenacapavir demonstrates the progress that continues to be made in HIV prevention. "The rollout of Lenacapavir represents a major scientific breakthrough in HIV prevention, one of the most significant advances in the field in recent years, and gives us another opportunity to strengthen HIV prevention in our communities. It expands the choices available to people who may benefit from a long-acting prevention option an…

Africa: 'One Injection Protects Up to Six Months' - What Is New HIV Drug Lenacapavir? [RFI] As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about how the treatment works, whether the supply will meet demand and why developing an HIV vaccine remains a challenge.

HIV in South Africa: why rolling out a groundbreaking new shot will ... HIV in South Africa: why rolling out a groundbreaking new shot will miss a critical group of men PAUL BOWEN and RAJEN GOVENDER June 2, 2026 June 1, 2026 5 Mins Read THE first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy . The rollout, expected to begin in June 2026, prioritises adolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs. These are the right populations to start with. But one group repeatedly slips through the cracks: adult, employed men in mobile, male-dominated industries, who move between work sites and home, between long-term partners and casual or paid encounters. In epidemiology, they are a “ bridging population ”: people whose sexual networks connect higher-prevalence groups to lower-prevalence groups. In 2017, UNAIDS named the problem in its Blind Spot report , showing that men across sub-Saharan Africa are less likely than women to te…

W Cape begins roll out of HIV preventative injection, Lenacapavir Home | W Cape begins roll out of HIV preventative injection, Lenacapavir A health official holds Lenacapavir. Image Credits : Reuters SABC News 8 June 2026, 19:05 [SAST] Health authorities in the Western Cape have begun rolling out the groundbreaking anti-retro viral injection, Lenacapavir , at 22 sites in the Cape Metro. These areas, which carry the highest burden of disease fall within five subdistricts in the city and include townships like Delft, Khayelitsha, Gugulethu, Mfuleni and Nomzamo. The rollout of the HIV preventative injection, which is administered twice a year, has been described as a move towards the normalization of the response to HIV. New HIV infections in the Western Cape reached some 24 000 last year while, the province has the lowest prevalence of HIV in the country, authorities say this additional option in HIV prevention, will be game changer. The city and provincial sites are located in the densest populated areas across Cape Town. “What that brings us up to is five subdistricts in the metro, not all eight. Five, and I have just given you a distribution across the five between the provinci…

HIV in South Africa: why rolling out a groundbreaking new shot will miss a critical group of men https://www.europesays.com/africa/260641/ The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in…

South Africa: Did US Aid Cuts Break Precisely the Things We Need Most for the Lenacapavir Rollout? [spotlight] With a new six-monthly injection, South Africa last week launched the most promising new HIV prevention tool in years, but much of the infrastructure that made HIV prevention services accessible to high-risk groups has been dismantled over the last year. Spotlight asks whether we can successfully deliver this breakthrough technology without the trusted pathways decimated by cuts to aid from the United States.

South Africa: Gauteng Health Exceeds Lenacapavir Rollout Targets [SAnews.gov.za] The Gauteng Department of Health (GDoH) has recorded a massive milestone in its Lenacapavir rollout programme, comfortably surpassing its targets in the very first month of rolling out the groundbreaking HIV prevention drug.